Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Krishnamurthy

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|September 12, 2014
Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomographyArvind Krishnamurthy, Ramachandran Krishna Kumar, Praveen Ravishankaran, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 6, 2026
Oral microbiota in early- and late-onset tongue cancers: A pilot case-control studyKrithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, et al.
Ecancermedicalscience|September 26, 2022
Metaplastic carcinoma of the breast: real-world outcome from a tertiary cancer centre in IndiaAnanthi Balasubramanian, Priya Iyer, Rama Ranganathan, et al.
Indian Journal of Cancer|July 18, 2020
Study of pathological complete response rate with neoadjuvant concurrent chemoradiation with paclitaxel in locally advanced breast cancerPriya Iyer, Venkatraman Radhakrishnan, Ananthi Balasubramanian, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 29, 2022
Exome Sequencing with Validations and Expression of p16/CDKN2A Shows no Association with HPV in Oral CancersVidyarani Shyamsundar, Soundara Viveka Thangaraj, Arvind Krishnamurthy, et al.
Journal of Personalized Medicine|February 25, 2022
Integrated Proteomics Based on 2D Gel Electrophoresis and Mass Spectrometry with Validations: Identification of a Biomarker Compendium for Oral Submucous Fibrosis-An Indian StudyDivyambika Catakapatri Venugopal, Soundharya Ravindran, Vidyarani Shyamsundar, et al.
Biomicrofluidics|October 22, 2015
Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cellsNihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 10, 2018
Association of DFNA5, SYK, and NELL1 variants along with HPV infection in oral cancer among the prolonged tobacco-chewersSharbadeb Kundu, Vijayalakshmi Ramshankar, Akalesh Kumar Verma, et al.
Biomicrofluidics|September 5, 2017
Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)]Nihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2026
Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Locally Advanced Inoperable Breast Cancer- A Phase 2 Randomized Controlled Trial (NEOTRAC STUDY)Priya Iyer, Arvind Krishnamurthy, Sridevi Velusamy, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|September 12, 2014
Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomographyArvind Krishnamurthy, Ramachandran Krishna Kumar, Praveen Ravishankaran, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 6, 2026
Oral microbiota in early- and late-onset tongue cancers: A pilot case-control studyKrithiga Shridhar, Arvind Krishnamurthy, Vijayalakshmi Ramshankar, et al.
Ecancermedicalscience|September 26, 2022
Metaplastic carcinoma of the breast: real-world outcome from a tertiary cancer centre in IndiaAnanthi Balasubramanian, Priya Iyer, Rama Ranganathan, et al.
Indian Journal of Cancer|July 18, 2020
Study of pathological complete response rate with neoadjuvant concurrent chemoradiation with paclitaxel in locally advanced breast cancerPriya Iyer, Venkatraman Radhakrishnan, Ananthi Balasubramanian, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 29, 2022
Exome Sequencing with Validations and Expression of p16/CDKN2A Shows no Association with HPV in Oral CancersVidyarani Shyamsundar, Soundara Viveka Thangaraj, Arvind Krishnamurthy, et al.
Journal of Personalized Medicine|February 25, 2022
Integrated Proteomics Based on 2D Gel Electrophoresis and Mass Spectrometry with Validations: Identification of a Biomarker Compendium for Oral Submucous Fibrosis-An Indian StudyDivyambika Catakapatri Venugopal, Soundharya Ravindran, Vidyarani Shyamsundar, et al.
Biomicrofluidics|October 22, 2015
Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cellsNihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 10, 2018
Association of DFNA5, SYK, and NELL1 variants along with HPV infection in oral cancer among the prolonged tobacco-chewersSharbadeb Kundu, Vijayalakshmi Ramshankar, Akalesh Kumar Verma, et al.
Biomicrofluidics|September 5, 2017
Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)]Nihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2026
Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Locally Advanced Inoperable Breast Cancer- A Phase 2 Randomized Controlled Trial (NEOTRAC STUDY)Priya Iyer, Arvind Krishnamurthy, Sridevi Velusamy, et al.
Pageof 15